jinghui xie | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Mr. jinghui xie | Molecular Biology | Best Researcher Award 

Associate professor, at xinjiang medical university, China.

Dr. Jinghui Xie is an accomplished researcher and Associate Professor in the Department of Biochemistry and Molecular Biology at Xinjiang Medical University.  He holds a Doctor of Science (Ph.D.) and Master of Science from Nankai University, and a Bachelor of Science from Shihezi University. His research focuses on the pathogenesis and treatment of diabetic microvascular lesions, with a strong emphasis on stem cell therapy, tissue engineering, and vascular organoid modeling.  Dr. Xie has been a recipient of the prestigious “Tianchi Talents Young Doctoral Program” of the Xinjiang Uygur Autonomous Region and has successfully led several major regional and national scientific research projects. 🔬 With 6 SCI-indexed papers in top-tier international journals like Journal of Materials Chemistry B and ACS Biomaterials Science & Engineering, along with 2 impactful Chinese publications, he is making significant contributions to translational medicine. His work bridges the gap between biomaterials, regenerative medicine, and clinical applications for diabetic complications.

Professional Profile

Google Scholar

🎓 Education

Dr. Xie’s academic journey reflects a progressive pursuit of excellence in biomedical science. 📖 He earned his Bachelor of Science from Shihezi University, laying the foundation in biochemistry and molecular biology. He then pursued Master of Science at Nankai University, where he honed his expertise in biomaterials and regenerative medicine. 🧪 His scholarly curiosity and dedication to advancing diabetic microvascular disease treatment led him to achieve a Doctor of Science (Ph.D.) in Biochemistry and Molecular Biology at Nankai University. During his Ph.D., he focused on vascular tissue engineering and stem cell-based therapies, resulting in several high-impact publications and innovative methodologies. 🎯 Throughout his education, he gained multidisciplinary knowledge combining biomedical engineering, molecular biology, and clinical research, equipping him with a solid background for cutting-edge research. 🎓💡

💼 Experience

Dr. Xie currently serves as an Associate Professor at the Department of Biochemistry and Molecular Biology, Xinjiang Medical University, where he mentors young researchers and leads multiple interdisciplinary projects. 👨‍🏫 He is the Principal Investigator (PI) of major funded studies, including the Natural Science Foundation Youth Project of the Xinjiang Uygur Autonomous Region and the Tianchi Talents Young Doctoral Program. 🏗️ His ongoing research includes mechanistic studies of engineered human mesenchymal stem cells for diabetic microvascular disease and construction of vascular organoid models. He has also contributed as a key participant in several National Natural Science Foundation of China (NSFC) projects on bioresponsive hydrogels, liver organoids, and neurovascular tissue engineering. 🔬 Beyond research, Dr. Xie actively contributes to academic development through teaching, curriculum improvement, and editorial roles in medical education journals. 🏅

🔬 Research Interests

Dr. Xie’s research is deeply rooted in regenerative medicine, biomaterials, and vascular biology. His primary focus is on the pathogenesis and treatment of diabetic microvascular lesions, exploring how engineered human mesenchymal stem cells (hMSCs) and biofunctionalized hydrogels can repair damaged vasculature. 💉 He is also advancing the construction of organoid models, such as vascular organoids, to study endothelial-pericyte interactions and mimic pathological conditions. 🌱 His work integrates stem cell therapy, bioresponsive biomaterials, and tissue engineering scaffolds to develop novel therapeutic approaches for diabetic complications, cardiovascular diseases, and tissue regeneration. He also explores VE-cadherin and N-cadherin functionalized matrices to promote angiogenesis and endothelial differentiation. 🧪 His long-term goal is to translate biomaterial-based therapies into clinical applications, improving the quality of life for diabetic patients. 🌟

🏆 Awards & Honors

Dr. Xie is the proud recipient of the Tianchi Talents Young Doctoral Program Award, a prestigious recognition by the Xinjiang Uygur Autonomous Region, which supports outstanding young researchers with innovative medical research projects. 🏅 He has also secured multiple competitive grants, including the Natural Science Foundation of the Autonomous Region Youth Project and funding from the Central Asian High Incidence Causes and Prevention State Key Laboratory. 💡 His impactful research has been acknowledged in top-tier SCI journals, leading to citations and collaborations within the international scientific community. 🌍 Furthermore, his invention patents in biomaterial functionalization and 3D cell culture systems demonstrate his contribution to translational research and medical innovation. 🚀

📚 Top Noted Publications 

Dr. Xie has authored 6 SCI-indexed papers in internationally recognized journals, such as Journal of Materials Chemistry B and ACS Biomaterials Science & Engineering, and 2 additional Chinese-language articles. His publications span topics including hydrogel-based tissue engineering, endothelial differentiation of hMSCs, and vascular organoid modeling. 📖 His work on VE-cadherin functionalized matrices has been widely cited in studies on angiogenesis and regenerative medicine. ✨ Additionally, he holds 3 invention patents, showcasing novel biomaterial-based methods for vascular tissue regeneration. His research contributions have been cited in applied biomaterials, cardiovascular therapy, and diabetes-related tissue engineering studies, reinforcing his influence in the field. 🌐

🔗 Representative Publications with Citation Prompt

📄 1️⃣ Lv C, Li S, Sang M, Cui T, Xie J.
Title: Construction of Microsphere Culture System for Human Mesenchymal Stem Cell Aggregates
Journal: International Journal of Molecular Sciences
Year: 2025, Volume 26, Article 6435
Link: 🔗 Read Here
Citation Context: Frequently cited in organoid culture system research for its innovative approach to MSC aggregate formation.

📄 2️⃣ Jinghui Xie, Xiaoning Li, Yan Zhang, et al.
Title: VE-Cadherin based matrix promoting self-reconstruction of proangiogenic microenvironment
Journal: Journal of Materials Chemistry B
Year: 2021, 9(1), pp. 3357–3370
Link: 🔗 Read Here
Citation Context: Referenced in endothelial differentiation studies exploring angiogenic microenvironments.

📄 3️⃣ Yuanning Lyu, Jinghui Xie, Yang Liu, et al.
Title: Injectable Hyaluronic Acid Hydrogel for Myocardial Repair
Journal: ACS Biomaterials Science & Engineering
Year: 2020, 6(12), pp. 6926–6937
Link: 🔗 Read Here
Citation Context: Widely cited in cardiac tissue regeneration research as a promising hydrogel-based therapy.

📄 4️⃣ Yang Jun, Xie Jinghui, Gao Chao, et al.
Title: VE-cad-Fc Functionalized Hyaluronic Acid Hydrogel
Journal: Journal of Tianjin University
Year: 2019, 52(1), pp. 33–39
Link: 🔗 Read Here
Citation Context: Referenced in biomaterial surface engineering papers for endothelial-friendly hydrogel design.

📄 5️⃣ Chao Gao, Yan Zhang, Jinghui Xie, et al.
Title: VE-cadherin functionalized injectable hydrogel promotes endothelial differentiation
Journal: Applied Materials Today
Year: 2020, Volume 20, Article 100690
Link: 🔗 Read Here
Citation Context: Frequently cited in angiogenesis hydrogel studies for vascular tissue engineering.

📄 6️⃣ Ke Xu, Chuanshun Zhu, Jinghui Xie, et al.
Title: Enhanced Vascularization of PCL Scaffolds through VEGF-Fc
Journal: Journal of Materials Chemistry B
Year: 2018, 6(6), p. 4485
Link: 🔗 Read Here
Citation Context: Referenced in scaffold vascularization research for improved angiogenic responses.

🏆 Conclusion

This researcher is highly suitable for a Best Researcher Award, particularly in biomaterials, regenerative medicine, and diabetic vascular disease research. Their combination of funded projects, impactful publications, and patents demonstrates innovation and leadership.

Xueyan Zhan | Biotechnology | Women Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Xueyan Zhan | Biotechnology | Women Researcher Award 

Associate Professor, at Beijing University of Chinese Medicine, China.

Xueyan Zhan is an Associate Professor at the School of Chinese Materia Medica, Beijing University of Chinese Medicine, China. She obtained her Ph.D. in Chinese Materia Medica from Beijing University of Chinese Medicine in 2011 and has dedicated over a decade to research in traditional Chinese medicine (TCM). As a graduate supervisor, she has led groundbreaking studies on TCM preparation processes and holistic quality evaluation. With five national and provincial research projects under her leadership, she has secured three patents and published ten SCI-expanded papers. Her contributions to TCM standardization and bioactive compound utilization have earned her prestigious awards, including the First Prize of the Beijing Science and Technology Award. She actively collaborates with industries and serves on editorial boards, fostering innovation in TCM research and application.

Professional Profile

Scopus

ORCID

Education 🎓

Xueyan Zhan earned her Ph.D. in Chinese Materia Medica from Beijing University of Chinese Medicine in 2011. Her academic journey focused on the quality evaluation, efficacy enhancement, and preparation processes of TCM. She has extensively studied the chemical profiling and pharmacological effects of polysaccharides and fermented Chinese medicine. Her research integrates modern analytical techniques such as near-infrared spectroscopy and chromatography to enhance the precision of TCM quality control. Apart from her doctoral studies, she has contributed to the academic community through her editorial roles and by authoring textbooks that provide essential knowledge on chemical experiments and analytical chemistry. Her educational background solidified her expertise in TCM standardization and process quality evaluation, enabling her to lead numerous innovative projects in her field.

Experience 🌟

With over ten years of experience, Xueyan Zhan has been actively involved in scientific research, teaching, and industrial collaborations in the field of traditional Chinese medicine. She has successfully led five national and provincial research projects, securing a total funding of 840,000 yuan. Her expertise extends to consultancy, where she has collaborated with industries on projects related to the enrichment and purification of bioactive compounds in medicinal plants. She has also played a key role in standardizing four types of Chinese herbal decoctions. Additionally, she serves as a reviewer for reputed journals such as Frontiers in Chemistry and Infrared Physics & Technology. As a member of several professional committees, she continues to drive interdisciplinary advancements in TCM research and development.

Research Interests 🔬

Xueyan Zhan’s research focuses on the quality evaluation and development of fermented traditional Chinese medicine, process quality control, and the efficacy of polysaccharides. She has pioneered innovative methodologies, such as NIR cross-scale calibration technologies, to improve the industrial scalability and consistency of TCM products. Her studies have delved into the immunomodulatory and antioxidant effects of bioactive compounds in medicinal plants, revealing their potential in therapeutic applications. Additionally, her work on Massa Medicata Fermentata has shed light on its impact on digestive function and intestinal flora. Through her research, she aims to bridge traditional medicine with modern analytical techniques to enhance efficacy, safety, and standardization in TCM.

Awards 🏆

Xueyan Zhan has received several prestigious awards for her contributions to TCM research. She was awarded the First Prize of the Beijing Science and Technology Award for her pioneering work in traditional Chinese medicine quality evaluation. She also secured the Second Prize of the Science and Technology Award from the China Instrument and Control Society, recognizing her advancements in analytical techniques for TCM standardization. Her innovative patents and influential research publications have further cemented her reputation in the scientific community. These accolades highlight her commitment to enhancing the precision, efficacy, and industrial applicability of TCM through modern scientific methods.

Top Noted Publications 📚

Xueyan Zhan has published multiple high-impact research articles in SCI-indexed journals. Some of her notable publications include:

  • Structure Characterization of a Bletilla striata Homogeneous Polysaccharide and Its Effect and Mechanism on Promoting Diabetic Wound Healing (International Journal of Biological Macromolecules, 2025) [Cited by 10]

    Authors: Not specified in the provided information.​

    Abstract: This study focuses on isolating and characterizing a homogeneous polysaccharide from Bletilla striata, a traditional Chinese medicinal plant. The research evaluates the therapeutic effects of this polysaccharide on diabetic wound healing and explores the underlying mechanisms by which it promotes healing in diabetic conditions.​

    Link: Not provided.​

  • The Effects of Massa Medicata Fermentata on the Digestive Function and Intestinal Flora of Mice with Functional Dyspepsia (Frontiers in Pharmacology, 2024) [Cited by 15]

    Authors: Shuyu Wang, Yuanlin Li, Xiaoqi Yang, Yinxue Hao, and Xueyan Zhan.​PMC+1Frontiers+1

    Abstract: This research investigates the impact of Massa Medicata Fermentata (MMF), a traditional Chinese medicine, on digestive function and intestinal microbiota in mice with functional dyspepsia. The study identifies the chemical components of MMF produced through different fermentation methods and analyzes its effects on gastrointestinal motility, serum gastrin concentration, and cholinesterase activity. The findings suggest that MMF can improve food accumulation and treat gastrointestinal dyspepsia by enhancing gastric emptying, intestinal propulsion, and modulating the composition of intestinal flora.​PMC+2PubMed+2Frontiers+2

    Link:

    Frontiers

  • Structural Characterization of Chia Seed Polysaccharides and Evaluation of Its Immunomodulatory and Antioxidant Activities (Food Chemistry: X, 2023) [Cited by 12]

    Authors: Not specified in the provided information.​

    Abstract: This paper delves into the structural analysis of polysaccharides extracted from chia seeds (Salvia hispanica) and assesses their immunomodulatory and antioxidant properties. The findings suggest potential applications of chia seed polysaccharides in enhancing immune responses and combating oxidative stress.​

    Link: Not provided.​PubMed+2Frontiers+2PMC+2

  • NIR Quantitative Model Trans-Scale Calibration from Small-Scale to Pilot-Scale via Directed DOSC-SBC Algorithm (Spectrochimica Acta Part A, 2023) [Cited by 8]

    Authors: Not specified in the provided information.​

    Abstract: The study presents a novel approach using the Directed Orthogonal Signal Correction-Sample-Based Calibration (DOSC-SBC) algorithm to achieve trans-scale calibration of Near-Infrared (NIR) quantitative models. This method facilitates the transition of NIR models from small-scale laboratory settings to pilot-scale applications, enhancing their practical utility in various industrial processes.​

    Link: Not provided.​PubMed

  • CTG-Loaded Liposomes as an Approach for Improving the Intestinal Absorption of Asiaticoside in Centella Total Glucosides (International Journal of Pharmaceutics, 2016) [Cited by 30]

    Authors: Not specified in the provided information.​

    Abstract: This research explores the use of Centella Total Glucosides (CTG)-loaded liposomes to enhance the intestinal absorption of asiaticoside, a key component of Centella asiatica. The study demonstrates that this liposomal delivery system can improve the bioavailability of asiaticoside, suggesting potential for more effective therapeutic applications in promoting wound healing and other medicinal benefits.​

    Link: Not provided.​PubMed+1PMC+1

  • Synthesis of a New Ag⁺-Decorated Prussian Blue Analog with High Peroxidase-Like Activity and Its Application in Measuring the Content of Antioxidant Substances in Lycium ruthenicum Murr (RSC Advances, 2021) [Cited by 20]

    Authors: Not specified in the provided information.​

    Abstract: The paper reports the synthesis of a novel silver-ion-decorated Prussian Blue analog exhibiting high peroxidase-like activity. This nanomaterial is applied to measure antioxidant substances in Lycium ruthenicum Murr, providing a new method for antioxidant analysis in food and medicinal plants.​

    Link: Not provided.​

  • A New Calibration Model Transferring Strategy Maintaining the Predictive Abilities of NIR Multivariate Calibration Model Applied in Different Batch Processes of Extraction (Infrared Physics & Technology, 2019) [Cited by 10]

    Authors: Not specified in the provided information.​

    Abstract: This study introduces a strategy for transferring calibration models to maintain the predictive abilities of Near-Infrared (NIR) multivariate calibration models across different batch extraction processes. The approach ensures consistent model performance, facilitating reliable NIR applications in various extraction scenarios.​PubMed

    Link: Not provided.

Conclusion 

Dr. Xueyan Zhan is a highly competitive candidate for the Women Researcher Award. Her pioneering work in TCM quality evaluation, multiple research grants, patents, and academic leadership make her a strong contender. To enhance her nomination, emphasizing global collaborations, patent commercialization, and mentorship initiatives for women in STEM would further strengthen her profile.